Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART trial of single versus dual antiplatelet therapy after left atrial appendage closure
2021-000730-34Phase 4Active
- Sponsor
- Fondazione Toscana Gabriele Monasterio
- Start
- Jun 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of clopidogrel and aspirin in Atrial fibrillation (AFib) (2 arms), sponsored by Fondazione Toscana Gabriele Monasterio. Started Jun 2021; status: active.
02
Drugs
clopidogrelaspirin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2021-000730-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000730-34.